Navegar por "Oncoloxía Radioterápica"

Mostrando ítems 1-10 de 10

Assessment of ADC value when comparing two methods to reduce geometrical distortion in DWMRI

2019- López Medina, Antonio; Garcia, A.; Perez, C.; Montesinos, P.; NIETO PARGA, ANGEL; [et al.]
Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

2019- Gómez Caamaño, Antonio; González-San Segundo, C.; Henríquez, I.; Maldonado, X.; Zapatero, A. [et al.]
GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic

2020- Counago, F.; Navarro-Martin, A.; Luna, J.; de Dios, N. R.; Rodriguez, A.; [et al.]
Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions

2019- Couñago, F.; Luna, J.; Guerrero, L. L.; Vaquero, B.; Guillén-Sacoto, M. C.; [et al.]
Phase II trial: melatonin oral gel for prevention of mucositis in oropharynx and oral cavity tumors

2019- Borbalas, A. L.; Marruecos, J.; Rubio-Casadevall, J.; Farre, N.; Lopez-Pousa, A.; [et al.]
Phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for SMALL-CELL LUNG Cancer

2019- De Dios, N. R.; Murcia, M.; Counago, F.; Lopez, J.; Oses, M. R.; [et al.]
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group

2021- Guirado, M.; Sanchez-Hernandez, A.; Pijuan, L.; Teixido, C.; Gómez Caamaño, Antonio; [et al.]
Radiotherapy impact on quality of life in localised prostate cancer: validation of EPIC-16 in Spain

2019- Laborda, A. Z.; Pijoan, X. M.; Gómez Caamaño, Antonio; Masferrer, J. P.; Hernandez, V. M.; [et al.]
Re-salvage treatment for locally recurrent prostate cancer by HDR brachytherapy guided by MRI and US

2019- García Pérez, Ana; Willisch Santamaría, Patricia; Martínez Agra, Marta; Gonzalez Castro, A.; Andrade Alvarez, Benito; [et al.]
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

2019- Seibold, P.; Webb, A.; Aguado-Barrera, M. E.; Azria, D.; Bourgier, C.; [et al.]